4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with kn 93 in 1 studies
Studies (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Trials (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Recent Studies (post-2010) (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Studies (kn 93) | Trials (kn 93) | Recent Studies (post-2010) (kn 93) |
---|---|---|---|---|---|
27 | 0 | 5 | 499 | 0 | 181 |
Protein | Taxonomy | 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol (IC50) | kn 93 (IC50) |
---|---|---|---|
Calcium/calmodulin-dependent protein kinase type II subunit beta | Rattus norvegicus (Norway rat) | 8.4 | |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | 8.4 | |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | Rattus norvegicus (Norway rat) | 8.4 | |
Myosin light chain kinase, smooth muscle | Gallus gallus (chicken) | 9.8 | |
Calcium/calmodulin-dependent protein kinase type II subunit delta | Rattus norvegicus (Norway rat) | 8.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunn, JM; Inderwies, BR; Licata, SC; Pierce, RC | 1 |
1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and kn 93
Article | Year |
---|---|
Repeated administration of AMPA or a metabotropic glutamate receptor agonist into the rat ventral tegmental area augments the subsequent behavioral hyperactivity induced by cocaine.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cocaine; Dioxolanes; Drug Synergism; Excitatory Amino Acid Agonists; Male; Microinjections; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Sulfonamides; Ventral Tegmental Area | 2005 |